Cannabis oil trial aims to ease cancer Patients' daily suffering
NCT ID NCT07459920
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study tests whether a cannabis extract oil containing THC and CBD can reduce the overall symptom burden in people with advanced solid tumors who are already taking strong painkillers. About 156 participants will receive either the cannabis oil or a placebo for 8 weeks. The main goal is to see if the cannabis oil improves total symptom scores, including pain, nausea, and fatigue.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cannabis extract oil (10 mg/ml THC and 10 mg/ml CBD)
What this could lead to
If it works, this could offer a new way to reduce multiple symptoms like pain, nausea, and poor appetite in advanced cancer patients.
What could go wrong
This is a phase 2 trial with only 156 people, so results are preliminary. The cannabis extract may cause side effects like dizziness or drowsiness, and it might not improve symptoms more than placebo.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED MALIGNANT SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
IRCCS Fondazione G. Pascale
Naples, Italy
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••